thalidomide has been researched along with Anti-MuSK Myasthenia Gravis in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sakano, S | 1 |
| Matsuyama, H | 1 |
| Ishikawa, H | 1 |
| Shindo, A | 1 |
| Ii, Y | 1 |
| Matsuura, K | 1 |
| Mizutani, M | 1 |
| Kawada, N | 1 |
| Tomimoto, H | 1 |
| Li, S | 1 |
| Cao, Y | 1 |
| Li, L | 1 |
| Zhang, H | 1 |
| Lu, X | 1 |
| Bo, C | 1 |
| Kong, X | 1 |
| Liu, Z | 1 |
| Chen, L | 1 |
| Liu, P | 1 |
| Jiao, Y | 1 |
| Wang, J | 1 |
| Ning, S | 1 |
| Wang, L | 1 |
| Crain, E | 1 |
| McIntosh, KR | 1 |
| Gordon, G | 1 |
| Pestronk, A | 1 |
| Drachman, DB | 1 |
3 other studies available for thalidomide and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies during therapy for multiple myeloma: a case report.
Topics: Antineoplastic Agents; Autoantibodies; Bortezomib; Humans; Male; Middle Aged; Multiple Myeloma; Myas | 2020 |
Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis.
Topics: Adalimumab; Carnosine; Databases, Genetic; Databases, Pharmaceutical; Drug Repositioning; Etanercept | 2019 |
The effect of thalidomide on experimental autoimmune myasthenia gravis.
Topics: Animals; Antibody Formation; Autoantibodies; Autoimmune Diseases; Drug Evaluation, Preclinical; Immu | 1989 |